Mutation of cysteine 21 inhibits nucleophosmin/B23 oligomerization and chaperone activity

International Journal of Biochemistry and Molecular Biology

Volumn 2, Issue 1, 2011, Pages 24-30

  Prinos, Panagiotis ^b   Lacoste, Marie Claude ^b   Wong, Judy ^b   Bonneau, Anne Marie ^b   Georges, Elias ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

Chaperone; Nucleolar protein; Nucleophosmin (NPM B23); Nucleophosmin B23 oligomerization; Oncogene; Tumor suppressor

Indexed keywords

CHAPERONE; CYSTEINE; CYSTEINE 21; NUCLEOPHOSMIN; PHENYLALANINE; UNCLASSIFIED DRUG;

ALPHA HELIX; AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DELETION MUTANT; HUMAN; HUMAN CELL; MUTATION; NONHUMAN; OLIGOMERIZATION; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PURIFICATION; SITE DIRECTED MUTAGENESIS;

EID: 79952145214     PISSN: None     EISSN: 21524114     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Grisendi S, Meeureci C, Falini B, Pandolfi PP. Nucleophosmin and cancer. Natl Rev Cancer 2006; 6: 493-505.
2. Schwarzacher HG, Mosgoeller W. Ribosome biogenesis in man: Current views on nucleolar structures and function. Cytogenet Cell Genet 2000; 91: 243-252.
3. Wang D, Baumann A, Szebeni A, Olson MO. The Nucleic Acid Binding Activity of Nucleolar Protein B23.1 Resides in Its Carboxyl-terminal End. J Biol Chem 1994; 269: 30994-30998.
4. Dumbar TS, Gentry GA, Olson MO. Interaction of nucleolar phosphoprotein B23 with nucleic acids. Biochemistry 1989; 28: 9495-9501.
5. Itahana K, Bhat KP, Jin A, Itahana Y, Hawke D, Kobayashi R, Zhang Y. Tumor Suppressor ARF Degrades B23, a Nucleolar Protein Involved in Ribosome Biogenesis and Cell Proliferation. Mol Cell 2003; 12: 1151-1164.
6. Borer RA, Lehner CF, Eppenberger HM, Nigg EA. Major Nucleolar Proteins Shuttle between Nucleus and Cytoplasm. Cell 1989; 56: 379-390.
7. Szebeni A, Herrera JE, Olson MO. Interaction of nucleolar protein B23 with peptides related to nuclear localization signals. Biochemistry 1995; 34: 8037-8042.
8. Li YP, Busch RK, Valdez BC, Busch H. (1996). C23 interacts with B23, a putative nucleolarlocalization- signal-bindinpg rotein. Eur J Biochem 237: 153-158.
9. Valdez BC, Perlaky L, Henning D, Saijo Y, Chan PK, Busch H. Identification of the Nuclear and Nucleolar Localization Signals of the Protein p120. J Biol Chem 1994; 269: 23776-23783.
10. Takemura M, Ohoka F, Perlepescu M, Ogawa M, Matsushita H, Takaba T, Akiyama T, Umekawa H, Furuichi Y, Cook PR, Yoshida S. Phosphorylation- Dependent Migration of Retinoblastoma Protein into the Nucleolus Triggered by Binding to Nucleophosmin/ B23. Exp Cell Res 2002; 276: 233-241.
11. Kondo T, Minamino N, Nagamura-Inoue T, Matsumoto M, Taniguchi T. Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity. Oncogene 1997; 15: 1275-1281.
12. Colombo E, Marine J-C, Danovi D, Falini B, Pelicci PG. Nucleophosmin regulates the stability and transcriptional activity of p53. Nat Cell Biol 2002; 4: 529-533.
13. Szebeni A, Olson MO. Nucleolar protein B23 has molecular chaperone activities, Protein Sci 1999; 8: 905-912.
14. Okuwaki M, Matsumoto K, Tsujimoto M, Nagata K. Function of nucleophosmin/B23, a nucleolar acidic protein, as a histone chaperone. FEBS Lett. 2001; 506: 272-276.
15. Namboodiri VMH, Akey IV, Schmidt-Zachmann MS, Head JF, Akey CW. The Structure and Function of Xenopus NO38-Core, a Histone Chaperone in the Nucleolus. Structure 2004; 12: 2149-2160
16. Dutta S, Akey IV, Dingwall C, Hartman KL, Laue T, Nolte RT, Head JF, Akey CW. The Crystal Structure of Nucleoplasmin-Core: Implications for Histone Binding and Nucleosome Assembly. Mol. Cell 2001; 8: 841-853.
17. Hingorani K, Szebeni A, Olson MO. Mapping the Functional Domains of Nucleolar Protein B23. J Biol Chem 2000; 275: 24451-24457.
18. Chan WY, Liu QR, Borjigin J, Busch H, Rennert OM, Tease LA, Chan PK. Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 1989; 28: 1033-1039.
19. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994; 263: 1281-1284.
20. Redner RL, Rush EA, Faas S, Rudert WA, Corey SJ. The t(5;17) variant of acute promyelocytic leukemia expresses a nucleophosmin-retinoic acid receptor fusion. Blood 1996; 87: 882-886.
21. Yoneda-Kato N, Look AT, Kirstein MN, Valentine MB, Raimondi SC, Cohen KJ, Carrol AJ, Morris SW. The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid leukemia produces a novel fusion gene, NPM-MLF1. Oncogene 1996; 12: 265-275.
22. Grisendi S, Pandolfi PP. NPM mutations in acute myelogenous leukemia. N Engl J Med 2005; 352: 291-292.
23. Grisendi S, Bernardi R, Ross M, Cheng K, Manova L, Pandolf PP. Role of nucleophosmin in embryonic development and tumorigenesis. Nature 2005; 437: 147-153.
24. Yung BY-M, Chan P-K. Identification and characterization of a hexameric form of nucleolar phosphoprotein B23. Biochim Biophys Acta 1987; 925: 74-82.
25. Herrera JE, Correia JJ, Jones AE, Olson MO. Sedimentation Analyses of the Salt- and Divalent Metal Ion-Induced Oligomerization of Nucleolar Protein B23. Biochemistry 1996; 35: 2668-2673.
26. Enomoto T, Lindstrom MS, Jin A, Ke H, Zhang Y. Essential Role of the B23/NPM Core Domain in Regulating ARF Binding and B23 Stability. J. Biol. Chem. 2006; 281: 18463-18472.
27. Buchner J, Grallert H, Jacob U. Analysis of chaperone function using citrate synthase as nonnative substrate protein. Methods Enzymol 1998; 290: 323-338.
28. Bischof D, Pulford K, Mason DY, Morris SW. Role of the Nucleophosmin (NPM) Portion of the Non- Hodgkin's Lymphoma-Associated NPMAnaplastic Lymphoma Kinase Fusion Protein in Oncogenesis. Mol Cell Biol 1997; 17: 2312-2325.
29. Bertwistle D, Sugimoto M, Sherr CJ. Physical and Functional Interactions of the Arf Tumor Suppressor Protein with Nucleophosmin/B23. Mol Cell Biol 2004; 24: 985-996.
30. Cordell JL, Pulford KAF, Bigerna B, Roncador G, Banham A, Colombo E, Pelicci P-G, Mason DY, Falini B. Detection of Normal and Chimeric Nucleophosmin in Human Cells. Blood 1999; 93: 632-642.
31. [31] Korgaonkar C, Hagen J, Tompkins V, Frazier AA, Allamargot C, Quelle FW, Quelle DE. Nucleophosmin (B23) Targets ARF to Nucleoli and Inhibits Its Function. Mol Cell Biol 2005; 25: 1258-1271.
32. [32] Kurki S, Peltonen K, Latonen L, Kiviharju TM, Ojala PM, Meek D, Laiho M. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 2004; 5: 465-475.